0001470274-11-000002.txt : 20110617 0001470274-11-000002.hdr.sgml : 20110617 20110617144700 ACCESSION NUMBER: 0001470274-11-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110617 DATE AS OF CHANGE: 20110617 EFFECTIVENESS DATE: 20110617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: On Demand Therapeutics, Inc. CENTRAL INDEX KEY: 0001470274 IRS NUMBER: 263425852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-161457 FILM NUMBER: 11918182 BUSINESS ADDRESS: STREET 1: ONE INDUSTRIAL WAY, UNIT 1A CITY: TYNGSBORO STATE: MA ZIP: 01879 BUSINESS PHONE: (978) 649-2882 MAIL ADDRESS: STREET 1: ONE INDUSTRIAL WAY, UNIT 1A CITY: TYNGSBORO STATE: MA ZIP: 01879 D 1 primary_doc.xml X0704 D LIVE 0001470274 On Demand Therapeutics, Inc. ONE INDUSTRIAL WAY, UNIT 1A TYNGSBORO MA MASSACHUSETTS 01879 (978) 649-2882 DELAWARE None None Corporation true 2008 John T. Santini, Jr. c/o On Demand Therapeutics, Inc. One Industrial Way, Unit 1A Tyngsboro MA MASSACHUSETTS 01879 Executive Officer Director David Weber c/o On Demand Therapeutics, Inc. One Industrial Way, Unit 1A Tyngsboro MA MASSACHUSETTS 01879 Director Gil Kliman c/o InterWest Partners X, L.P. 2710 Sand Hill Road, 2d Floor Menlo Park CA CALIFORNIA 94025 Director Ajit Gill c/o MicroCHIPS. Inc. 6-B Preston Court Bedford MA MASSACHUSETTS 01730 Director Biotechnology Decline to Disclose 06 false 2011-03-25 false true true true Series A Preferred Stock and Convertible Promissory Notes and the underlying Common Stock issued upon conversion of such Preferred Stock and Notes. false 0 4124369 2624369 1500000 false 1 0 0 0 false On Demand Therapeutics, Inc. John T. Santini, Jr. John T. Santini, Jr. President and CEO 2011-06-17